Analyst downgrades Merck over two drugs

Analyst downgrades Merck over two drugs

There are 3 comments on the WETM-TV Elmira story from Feb 4, 2013, titled Analyst downgrades Merck over two drugs. In it, WETM-TV Elmira reports that:

Shares of drugmaker Merck & Co. declined after an analyst downgraded them from "Buy" to "Sell." Morgan Stanley & Co.

Join the discussion below, or Read more at WETM-TV Elmira.

Autism 4 Dummies

Winnipeg, Canada

#1 Feb 4, 2013
MERCK maims and kills and owners and employees serve no prison time.

Alasas, Philippines

#2 Feb 5, 2013
This news is quite sad.

San Jose, CA

#3 Feb 22, 2013
People with osteoporosis and osteopenia may need to be aware that Merck's drug, Fosamax, has been causing more health problems to people taking it. Merck has been facing lawsuits filed by injured consumers. There are articles I bumped into at that may be of great help to you if you want to know more about this matter.

Tell me when this thread is updated:

Subscribe Now Add to my Tracker

Add your comments below

Characters left: 4000

Please note by submitting this form you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

Biotech Discussions

Title Updated Last By Comments
News a CDC ban on 'fetus' and 'transgender?' Experts... 13 hr Wondering 102
News Merck grants free license for pediatric HIV drug (Feb '15) Dec 29 Seniors for Fairness 2
News Merck beats 1Q profit views with tight cost con... (May '16) Dec 29 Seniors for Fairness 2
News CDC banned from using words like fetus, transge... Dec 22 Trump is a joke 3
News a CDC ban on 'fetus' and 'transgender?' Experts... Dec '17 Imprtnrd 54
News Most actively traded companies on the TSX Dec '17 Joe 1
News Viagra goes generic: Pfizer to launch own littl... Dec '17 He Querried 1
More from around the web